These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1110 related articles for article (PubMed ID: 25981812)
1. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Chang JY; Senan S; Paul MA; Mehran RJ; Louie AV; Balter P; Groen HJ; McRae SE; Widder J; Feng L; van den Borne BE; Munsell MF; Hurkmans C; Berry DA; van Werkhoven E; Kresl JJ; Dingemans AM; Dawood O; Haasbeek CJ; Carpenter LS; De Jaeger K; Komaki R; Slotman BJ; Smit EF; Roth JA Lancet Oncol; 2015 Jun; 16(6):630-7. PubMed ID: 25981812 [TBL] [Abstract][Full Text] [Related]
2. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery. Chang JY; Mehran RJ; Feng L; Verma V; Liao Z; Welsh JW; Lin SH; O'Reilly MS; Jeter MD; Balter PA; McRae SE; Berry D; Heymach JV; Roth JA; Lancet Oncol; 2021 Oct; 22(10):1448-1457. PubMed ID: 34529930 [TBL] [Abstract][Full Text] [Related]
3. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Ball D; Mai GT; Vinod S; Babington S; Ruben J; Kron T; Chesson B; Herschtal A; Vanevski M; Rezo A; Elder C; Skala M; Wirth A; Wheeler G; Lim A; Shaw M; Schofield P; Irving L; Solomon B; Lancet Oncol; 2019 Apr; 20(4):494-503. PubMed ID: 30770291 [TBL] [Abstract][Full Text] [Related]
4. Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial. Chang JY; Lin SH; Dong W; Liao Z; Gandhi SJ; Gay CM; Zhang J; Chun SG; Elamin YY; Fossella FV; Blumenschein G; Cascone T; Le X; Pozadzides JV; Tsao A; Verma V; Welsh JW; Chen AB; Altan M; Mehran RJ; Vaporciyan AA; Swisher SG; Balter PA; Fujimoto J; Wistuba II; Feng L; Lee JJ; Heymach JV Lancet; 2023 Sep; 402(10405):871-881. PubMed ID: 37478883 [TBL] [Abstract][Full Text] [Related]
5. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360 [TBL] [Abstract][Full Text] [Related]
6. The optimal treatment for patients with stage I non-small cell lung cancer: minimally invasive lobectomy versus stereotactic ablative radiotherapy - a nationwide cohort study. de Ruiter JC; van der Noort V; van Diessen JNA; Smit EF; Damhuis RAM; Hartemink KJ; Lung Cancer; 2024 May; 191():107792. PubMed ID: 38621343 [TBL] [Abstract][Full Text] [Related]
7. Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer. Brooks ED; Sun B; Feng L; Verma V; Zhao L; Gomez DR; Liao Z; Jeter M; O'Reilly M; Welsh JW; Nguyen QN; Erasmus JJ; Eapen G; Ahrar K; Antonoff MB; Hahn SM; Heymach JV; Rice DC; Chang JY JAMA Netw Open; 2018 Aug; 1(4):e181390. PubMed ID: 30646121 [TBL] [Abstract][Full Text] [Related]
8. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial. Sun B; Brooks ED; Komaki RU; Liao Z; Jeter MD; McAleer MF; Allen PK; Balter PA; Welsh JD; O'Reilly MS; Gomez D; Hahn SM; Roth JA; Mehran RJ; Heymach JV; Chang JY Cancer; 2017 Aug; 123(16):3031-3039. PubMed ID: 28346656 [TBL] [Abstract][Full Text] [Related]
9. Stereotactic Ablative Radiation Therapy for Large (≥5 cm) Non-small Cell Lung Carcinoma. McDermott RL; Mihai A; Dunne M; Keys M; O'Sullivan S; Thirion P; ElBeltagi N; Armstrong JG Clin Oncol (R Coll Radiol); 2021 May; 33(5):292-299. PubMed ID: 33309479 [TBL] [Abstract][Full Text] [Related]
10. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis. Senthi S; Lagerwaard FJ; Haasbeek CJ; Slotman BJ; Senan S Lancet Oncol; 2012 Aug; 13(8):802-9. PubMed ID: 22727222 [TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial. Sun B; Brooks ED; Komaki R; Liao Z; Jeter M; McAleer M; Balter PA; Welsh JD; O'Reilly M; Gomez D; Hahn SM; Sepesi B; Rice DC; Heymach JV; Chang JY J Thorac Oncol; 2017 Jun; 12(6):983-992. PubMed ID: 28259750 [TBL] [Abstract][Full Text] [Related]
12. Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non-small cell lung cancer: A virtual randomized phase III trial stratified by age. Seo YS; Kim HJ; Wu HG; Choi SM; Park S Thorac Cancer; 2019 Jun; 10(6):1489-1499. PubMed ID: 31124275 [TBL] [Abstract][Full Text] [Related]
13. Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. Palma DA; Nguyen TK; Louie AV; Malthaner R; Fortin D; Rodrigues GB; Yaremko B; Laba J; Kwan K; Gaede S; Lee T; Ward A; Warner A; Inculet R JAMA Oncol; 2019 May; 5(5):681-688. PubMed ID: 30789648 [TBL] [Abstract][Full Text] [Related]
14. Interpreting survival data from clinical trials of surgery versus stereotactic body radiation therapy in operable Stage I non-small cell lung cancer patients. Samson P; Keogan K; Crabtree T; Colditz G; Broderick S; Puri V; Meyers B Lung Cancer; 2017 Jan; 103():6-10. PubMed ID: 28024698 [TBL] [Abstract][Full Text] [Related]
15. Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data. Rusthoven CG; Kavanagh BD; Karam SD Ann Transl Med; 2015 Jul; 3(11):149. PubMed ID: 26244136 [TBL] [Abstract][Full Text] [Related]
16. Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC. van den Berg LL; Klinkenberg TJ; Groen HJM; Widder J J Thorac Oncol; 2015 May; 10(5):826-831. PubMed ID: 25629639 [TBL] [Abstract][Full Text] [Related]
17. Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC). Palma DA; Nguyen TK; Kwan K; Gaede S; Landis M; Malthaner R; Fortin D; Louie AV; Frechette E; Rodrigues GB; Yaremko B; Yu E; Dar AR; Lee TY; Gratton A; Warner A; Ward A; Inculet R Radiat Oncol; 2017 Jan; 12(1):30. PubMed ID: 28129789 [TBL] [Abstract][Full Text] [Related]
18. Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer. de Ruiter JC; van Diessen JNA; Smit EF; van der Noort V; Damhuis RAM; Hartemink KJ; Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35348664 [TBL] [Abstract][Full Text] [Related]
19. Contact of a tumour with the pleura is not associated with regional recurrence following stereotactic ablative radiotherapy for early stage non-small cell lung cancer. Wink KCJ; Löck S; Rossi M; van Baardwijk A; Belderbos J; de Ruysscher D; Troost EGC Radiother Oncol; 2019 Feb; 131():120-126. PubMed ID: 30773178 [TBL] [Abstract][Full Text] [Related]
20. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. Shirvani SM; Jiang J; Chang JY; Welsh J; Likhacheva A; Buchholz TA; Swisher SG; Smith BD JAMA Surg; 2014 Dec; 149(12):1244-53. PubMed ID: 25321323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]